Gene Query: NOP9

Dataset Description Geneva Score
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 49.18
Genome wide expression change in LCC2 and MCF-7 cells 42.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 39.47
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 26.7
Genome wide miR-191 target profile determined by RIP and gene expression profiling 26.7
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 26.45
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 25.79
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 25.35
Peptidomimetic blockade of MYB in acute myeloid leukemia 25.35
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 25.1
Human HAP1 cells before and after nutrient deprivation 24.65
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 24.65
RNA-seq in transgenic cells 23.0
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 18.94
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 18.73
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 18.35
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 18.35
FOXD3 is a novel tumor suppressor in lung cancer 18.28
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 18.2
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 17.85
RNAseq Study in CC-671 Treated Cal-51 Cells 16.58
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 16.36
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 16.36
RNAseq of HEK293 cells after Chtop knockdown 16.2
Co-transcriptional loading of RNA export factors shapes the human transcriptome 16.2
DART-seq: an antibody-free method for global m6A detection 15.96
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 15.71
Transcriptome analysis in Neobractatin treated cells 15.3
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 15.01
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 14.46
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 14.24
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 14.14
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 13.63
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 13.44
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 13.28
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 13.28
RNA-seq analysis of BAP1-depleted uveal melanoma cells 12.63
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 12.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation 12.31
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 12.27
Transcriptome analysis of SKI knock-out in HL60 cells 12.27
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 12.12
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 12.03
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 12.03
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 11.85
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.65
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.65
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 11.59
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 11.53
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.49
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.35
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 11.13
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 11.04
Human cells contain natural double-stranded RNAs with potential regulatory capacity 11.02
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 10.97
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 10.97
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 10.95
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 10.78
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 10.77
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 10.77
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 10.75
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 10.7
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 10.66
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.55
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 10.52
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 10.43
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.3
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 10.24
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 10.19
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 10.1
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 9.96
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.89
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 9.67
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 9.54
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 9.51
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 9.35
A Unique Epigenomic Landscape Defines Human Erythropoiesis 9.35
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 9.32
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.31
Genome wide expression change by RNF168 knocking down in NEC cells 9.26
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.08
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.08
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 9.07
RNA-seq of naive and primed ES cells (NHSM) 9.03
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.0
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.0
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 8.95
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.93
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 8.91
Transcriptomic analysis of the HOTAIR-regulated genes 8.86
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 8.79
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 8.77
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 8.66
MYC dependent mRNA translation shapes gene expression and cell biology 8.66
Differential expression of genes in AD169-infected MRC5. 8.44
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.33
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.3
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 8.29
Endothelial gene expression analysis 8.29
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.25
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.2
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 8.16
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 8.05
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 7.96
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.96
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.96
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.9
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 7.83
RNA sequencing of primary human platelets and in vitro cell lines 7.83
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 7.79
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.78
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.78
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 7.68
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.56
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 7.51
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 7.46
MYCi361 regulates MYC target genes 7.43
Effect of FGF13 depletion on the H460 cell line 7.4
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 7.39
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 7.39
RNA-seq analysis of RALD iPSCs after in vitro differentiation 7.35
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 7.35
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.34
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.25
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 7.23
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 7.21
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 7.2
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.14
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 7.14
miRNAs affected by antagomiR-17 treatment 7.12
The landscape of alternative splicing in aggressive prostate cancers 7.1
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.04
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.01
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.0
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.97
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 6.91
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.9
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.9
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 6.89
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 6.88
Regulation of highly expressed hCINAP on translatome 6.86
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.85
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.85
Gene expression analysis of dengue-infected cells 6.85
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 6.81
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 6.8
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 6.8
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 6.77
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 6.77
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 6.75
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.74
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.72
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.72
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.71
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.71
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 6.68
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.68
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.68
Searching for target genes of miR-508/509/506/514 in HCT116 cells 6.65
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.63
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.63
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.62
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 6.62
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.6
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.58
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 6.57
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.56
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.52
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 6.49
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.49
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 6.47
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 6.45
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 6.45
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.45
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 6.38
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 6.36
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 6.36
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.32
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.3
RNA-seq of YB5 cells treated with Proscillaridin A 6.3
Transcriptomic analysis of LSD1 6.29
A sister of NANOG regulates genes expressed in pre-implantation human development 6.26
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.24
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 6.24
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.19
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.19
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.18
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.18
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.16
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 6.13
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.1
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.05
Gene expression changes caused by KRAS in MCF-10A 6.05
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 6.01
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.99
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.98
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 5.92
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.92
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.9
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.89
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 5.87
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 5.87
RNA-Seq with and without RNase treatment in PCa cell lines 5.83
Identification of Nrf2 regulated genes by RNA sequencing 5.83
Nrf2 regulated genes in A549 cells 5.83
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 5.83
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.77
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.77
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.77
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 5.77
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.74
MeRIP-seq for heat shock in B-cell lymphoma cells 5.73
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 5.73
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.73
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.73
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.68
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.66
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.65
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.59
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.58
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 5.57
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 5.56
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.56
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.54
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.54
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.48
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.48
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 5.48
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 5.48
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.46
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.44
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.42
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.41
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.4
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.39
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.38
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.38
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.38
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.34
SRSF1 role in cellular gene expression and splicing 5.34
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 5.32
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.3
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.3
Cajal bodies are linked to genome conformation [RNA-Seq] 5.3
Cajal bodies are linked to genome conformation 5.3
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.28
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 5.27
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 5.24
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 5.24
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.23
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 5.22
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 5.22
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.2
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.14
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 5.12
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.1
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.08
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.08
Landscape and variation of RNA secondary structure across the human transcriptome 5.08
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 4.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.99
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.98
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.96
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.96
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.94
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.92
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.92
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.86
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 4.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.82
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.82
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.81
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.81
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.81
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.8
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.8
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.74
RNA-seq analysis of control and Myc-induced U2OS cells 4.72
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.71
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.7
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.7
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.66
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.62
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 4.61
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 4.61
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.6
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.59
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 4.59
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.57
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.56
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 4.5
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.49
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.44
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.44
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.44
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.42
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.4
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.39
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.38
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.36
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 4.33
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.31
AUF-1 affected genes in human skin cells 4.25
U2AF1 mutations alter splice site recognition in hematological malignancies 4.23
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.21
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.19
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.18
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.17
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.13
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.13
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 4.12
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.1
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.09
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.05
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.04
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.99
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 3.97
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.88
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.82
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 3.77
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.74
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.66
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.64
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 3.64
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.55
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.55
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.53
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.48
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.46
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.43
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.43
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.37
N6-methyladenine DNA Modification in Glioblastoma 3.31
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.31
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.29
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.29
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.25
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.23
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.21
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.2
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.2
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.17
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.13
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 3.07
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.07
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 3.05
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.0
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.0
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 2.96
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 2.91
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.84
Expression profiling of MCF-7 cells with treatment of TCDD 2.84
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.78
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.78
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.77
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 2.76
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.73
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.69
Gene expression analysis in response to hypoxic pathway inhibition 2.66
Glioblastoma stem cells infected by ZIKA virus 2.64
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.63
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.62
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.61
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.61
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.54
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.51
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.41
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.39
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.39
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 2.32
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.31
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.3
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.29
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 2.28
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.25
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.24
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.21
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.2
Iron response of HepG2 cells 2.17
circRNA-sequencing 2.17
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.15
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.14
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.12
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.07
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 2.06
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 2.06
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.05
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.04
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.03
Gene expressions of H9s in different culture systems 2.0
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.98
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.97
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.97
RNA splicing alteration on glioblastoma and normal neural stem cells 1.96
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.83
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.81
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.58
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.58
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.57
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.57
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.57
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.56
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.54
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.49
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.46
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.46
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 1.44
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.42
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.41
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.38
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.38
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.37
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.35
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.35
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.25
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.25
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.16
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.15
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.11
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.11
MicroRNA-125a-5p overexpression in human macrophages 1.11
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.11
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.1
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.06
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.05
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.04
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.99
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.99
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.93
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.93
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.93
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.92
Global transcriptome analysis of WT versus HEB-/- hESCs 0.89
Targeted enhancer activation by a subunit of the integrator complex 0.79
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.77
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.77
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.76
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.75
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.73
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.71
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.7
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.7
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.68
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.58
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.57
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.56
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.56
Transcriptome-wide modulation of splicing by the exon junction complex 0.56
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.56
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.56
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.56
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.54
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.51
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.5
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.49
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.48
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.45
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.44
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.44
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.43
H1609088 Human RNA-Sequencing 0.43
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.4
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.36
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.35
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.35
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.34
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.31
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.31
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.29
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.29
The pioneer factor CEBPA modulates vitamin D signaling 0.29
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.26
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.26
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.26
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.25
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.24
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.23
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.23
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.17
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.17
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.15
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.14
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.13
The role of m6A/m-RNA methylation in stress response regulation 0.13
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.13
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.05
HEK293 TFAM Knockout Expression Study 0.04
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.04
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.0
Gene expression analysis of breast cancer cell-lines 0.0
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.0
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation